Journal of Adolescent Health
Volume 46, Issue 2, Supplement 2 , Pages S4-S8 , February 2010

Adolescents at Risk: The Case for Meningococcal Vaccine

  • Martin C. Mahoney, M.D., Ph.D., F.A.A.F.P., F.A.C.E.

      Affiliations

    • Department of Family Medicine, School of Medicine & Biomedical Sciences, SUNY at Buffalo, Buffalo, New York
    • School of Public Health and Health Professions, SUNY at Buffalo, Buffalo, New York
    • Corresponding Author InformationAddress correspondence to: Martin C. Mahoney, M.D., Ph.D., SUNY-Buffalo (RPCI), Elm and Carlton, Buffalo, NY 14263.
    • ,
  • Stephen I. Pelton, M.D.

      Affiliations

    • Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts
    • Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts

Received 9 July 2009 ,Accepted 10 December 2009.

References 

  1. Immunization Action Coalition . Vaccine information for the public and health professionals. Available at: http://www.vaccineinformation.org/photos/meni_mt002.jpgAccessed April 2, 2009
  2. Schoeller T, Schmutzhard E. Images in clinical medicine. Waterhouse-Friderichsen syndrome. N Engl J Med. 2001;344:1372
  3. Stephens DS, Munford RS, Wetzler LM. Meningococcal infections. In:  Kasper DL,  Braunwald E,  Fauci AS, et al  editor. Harrison's Principles of Internal Medicine. 16th edition. New York, NY: McGraw-Hill Professional; 2004;
  4. Wells LC, Smith JC, Weston VC, et al. The child with a non-blanching rash: How likely is meningococcal disease?. Arch Dis Child. 2001;85:218–222
  5. Wong VK, Hitchcock W, Mason WH. Meningococcal infections in children: A review of 100 cases. Pediatr Infect Dis J. 1989;8:224–227
  6. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369:2196–2210
  7. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54:1–21
  8. Goldacre MJ, Roberts SE, Yeates D. Case fatality rates for meningococcal disease in an English population, 1963-98: Database study. BMJ. 2003;327:596–597
  9. Rosenstein NE, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. 2001;344:1378–1388
  10. Kaplan SL, Schutze GE, Leake JA, et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics. 2006;118:e979–e984
  11. Centers for Disease Control and Prevention (CDC) . Meningococcal disease. In:  Atkinson W,  Wolfe S,  Hamborsky J, et al  editor. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th edition. Washington, DC: Public Health Foundation; 2009;Chap 12
  12. Finn R, Groves C, Coe M, et al. Cluster of serogroup C meningococcal disease associated with attendance at a party. South Med J. 2001;94:1192–1194
  13. Riordan T, Cartwright K, Andrews N, et al. Acquisition and carriage of meningococci in marine commando recruits. Epidemiol Infect. 1998;121:495–505
  14. Yazdankhah SP, Caugant DA. Neisseria meningitidis: An overview of the carriage state. J Med Microbiol. 2004;53:821–832
  15. Girgis N, Sultan Y, Frenck RW, et al. Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr Infect Dis J. 1998;17:816–819
  16. Advisory Committee on Immunization Practices (ACIP) . Centers for Disease Control and Prevention (CDC). Report from the Advisory Committee on Immunization Practices (ACIP): Decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). MMWR Morb Mortal Wkly Rep. 2008;57:462–465
  17. Wu HM, Harcourt BH, Hatcher CP, et al. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N Engl J Med. 2009;360:886–892
  18. Centers for Disease Control and Prevention . Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2007;56:794–795
  19. Jackson LA, Baxter R, Reisinger K, et al. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents. Clin Infect Dis. 2009;49:e1–e10
  20. Reisinger KS, Baxter R, Block SL, et al. Quadrivalent meningococcal vaccination in adults: A phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine. Menactra. Clin Vaccine Immunol. 2009;16:1810–1815
  21. Black S, Klein NP, Shah J, et al. Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age. Vaccine. 2009;28:657–663
  22. Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, Neisseria meningitidis, 2007. Available at: http://www.cdc.gov/abcs/survreports/mening07.pdf. Accessed November 5, 2009.
  23. Martin D, Lopez L. The epidemiology of meningococcal disease in New Zealand in 2007. Wellington, New Zealand: New Zealand Ministry of Health, Institute of Environmental Science and Research Limited; 2008;
  24. Burstein GR, Berman SM, Blumer JL, Moran JS. Ciprofloxacin for the treatment of uncomplicated gonorrhea infection in adolescents: Does the benefit outweigh the risk?. Clin Infect Dis. 2002;35(suppl 2):S191–S199
  25. CDC . Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005-September 2006. MMWR Morb Mortal Wkly Rep. 2006;55:1120–1124
  26. Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 7 through 18 years—United States, 2009. Available at: http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2009/09_7-18yrs_schedule_pr.pdf. Accessed June 11, 2009.
  27. Centers for Disease Control and Prevention . Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep. 2009;58:1042–1043

PII: S1054-139X(09)00681-8

doi: 10.1016/j.jadohealth.2009.12.013

Journal of Adolescent Health
Volume 46, Issue 2, Supplement 2 , Pages S4-S8 , February 2010

Article Tools

* Image Usage & Resolution